Document is current
Any future updates will be listed below
-
Authors
Engin, Burhan
Güler Özden, Müge
Karstarlı Bakay, Özge Sevil
Kartal, Selda Pelin
Zindancı, İlkin
Çınar, Salih Levent
Dursun, Recep
Pehlivan Ulutaş, Gizem
Özkök Akbulut, Tuğba Özkök
Hapa, Fatma Aslı
Bülbül Başkan, Emel
Melikoğlu, Mehmet
Polat Ekinci, Algün
Demirel Öğüt, Neslihan
Hızlı, Pelin
Türkoğlu, Zafer
Küçük, Özlem Su
Topkarcı, Zeynep
Türsen, Ümit
Canpolat, Filiz
Uçgun, Hanife
Yaşar, Şirin
Temiz, Selami Aykut
Doğramacı, Asena Çiğdem
Altuğ, Sedat
Kozlu, Serhat
Ulu, Nadir https://orcid.org/0000-0002-2681-8615
Serdaroğlu, Server
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct05706870 at ClinicalTrials.govDocuments that mention this clinical trial
A Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Phase 2 Study Evaluating the Efficacy and Safety of GN-037 Cream in Patients with Mild-to-Moderate Plaque Psoriasis
https://doi.org/10.1007/s13555-024-01301-1
-
Funding
Funding for this research was provided by:
This study was sponsored by Gen İlaç ve Sağlık Ürünleri A.Ş.
- License Information
-
More Information
Article History
Received: 13 September 2024
Accepted: 22 October 2024
First Online: 22 November 2024
Declarations
:
: Nadir Ulu and Serhat Kozlu report employment on Gen İlaç ve Sağlık Ürünleri A.Ş. Burhan Engin, Müge Güler Özden, Özge Sevil Karstarlı Bakay, Selda Pelin Kartal, İlkin Zindancı, Salih Levent Çınar, Recep Dursun, Gizem Pehlivan Ulutaş, Tuğba Özkök Akbulut, Fatma Aslı Hapa, Emel Bülbül Başkan, Mehmet Melikoğlu, Algün Polat Ekinci, Neslihan Demirel Öğüt, Pelin Hızlı, Zafer Türkoğlu, Özlem Su Küçük, Zeynep Topkarcı, Ümit Türsen, Filiz Canpolat, Hanife Uçgun, Şirin Yaşar, Selami Aykut Temiz, Asena Çiğdem Doğramacı, Sedat Altuğ and Server Serdaroğlu have nothing to disclose.
: The trial was carried out according to the ethical standards of the Declaration of Helsinki and the International Conference on Harmonization of Good Clinical Practice Guidelines and its revisions. The study protocol was approved by the Ethics Committee for Clinical Trials of Istanbul University-Cerrahpasa, Istanbul, Turkey, and the Republic of Turkey. Written informed consent was provided from all patients before enrollment.
